On 22nd of September we changed our brand name from TBD-Biodiscovery to TBD Pharmatech. The legal name will remain TBD-Biodiscovery Ltd. The change of the name means a new logo with a fresh visual identity…
Read more
March 20-23 2023 TBD Pharmatech will be present at DCAT Week 2023! This is the first time TBD Pharmatech is attending DCAT Week. We are already looking forward to discuss CDMO collaboration! Book a…
Read more
Inactive pharmaceutical ingredients (IPIs) are ingredients found in medication that do not directly affect the treatment of a disease or condition. While they may not be active, these components can…
Read more
TBD Pharmatech worked on a PET-diagnostics project together with Latvian partner SIA PharmIdea from 2017 until 2019. The main objective of the Project was to develop a PET-product used in Positron emission…
Read more
On 21st February 2023, the Latvian Institute of Organic Synthesis (LIOS) and TBD Pharmatech signed the Memorandum of Understanding to strengthen the drug manufacturing performance of the Baltic region….
Read more
Pharmaceutical compliance is a crucial part of the drug development process. It includes the processes and activities undertaken by a pharmaceutical company to ensure that its products meet all the…
Read more
On 9th of February the annual Maarjavälja career day 2023 took place. The career day is organized by Faculty of Science and Technology of University of Tartu. The event brings together companies and…
Read more
TBD Pharmatech (formerly TBD-Biodiscovery) specialises in Active Pharmaceutical Ingredients (API), advanced intermediates, and the development and production of fine chemicals.
